Loading...

Xcelerate Inc.

XCRTPNK
Healthcare
Medical - Care Facilities
$0.02
$-0.00(-6.09%)
U.S. Market is Open • 11:46

Xcelerate Inc. Fundamental Analysis

Xcelerate Inc. (XCRT) shows moderate financial fundamentals with a PE ratio of -29.79, profit margin of -22.83%, and ROE of 26.34%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE26.34%
PEG Ratio-0.30

Areas of Concern

Operating Margin-24.90%
Cash Position0.93%
Current Ratio0.24
We analyze XCRT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 52.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
52.7/100

We analyze XCRT's fundamental strength across five key dimensions:

Efficiency Score

Weak

XCRT struggles to generate sufficient returns from assets.

ROA > 10%
-17.08%

Valuation Score

Excellent

XCRT trades at attractive valuation levels.

PE < 25
-29.79
PEG Ratio < 2
-0.30

Growth Score

Weak

XCRT faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

XCRT shows balanced financial health with some risks.

Debt/Equity < 1
-1.81
Current Ratio > 1
0.24

Profitability Score

Moderate

XCRT maintains healthy but balanced margins.

ROE > 15%
26.34%
Net Margin ≥ 15%
-22.83%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is XCRT Expensive or Cheap?

P/E Ratio

XCRT trades at -29.79 times earnings. This suggests potential undervaluation.

-29.79

PEG Ratio

When adjusting for growth, XCRT's PEG of -0.30 indicates potential undervaluation.

-0.30

Price to Book

The market values Xcelerate Inc. at -7.27 times its book value. This may indicate undervaluation.

-7.27

EV/EBITDA

Enterprise value stands at -28.29 times EBITDA. This is generally considered low.

-28.29

How Well Does XCRT Make Money?

Net Profit Margin

For every $100 in sales, Xcelerate Inc. keeps $-22.83 as profit after all expenses.

-22.83%

Operating Margin

Core operations generate -24.90 in profit for every $100 in revenue, before interest and taxes.

-24.90%

ROE

Management delivers $26.34 in profit for every $100 of shareholder equity.

26.34%

ROA

Xcelerate Inc. generates $-17.08 in profit for every $100 in assets, demonstrating efficient asset deployment.

-17.08%

Following the Money - Real Cash Generation

Operating Cash Flow

Xcelerate Inc. generates limited operating cash flow of $37.83K, signaling weaker underlying cash strength.

$37.83K

Free Cash Flow

Xcelerate Inc. produces free cash flow of $37.82K, offering steady but limited capital for shareholder returns and expansion.

$37.82K

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

XCRT converts 0.47% of its market value into free cash.

0.47%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-29.79

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.30

vs 25 benchmark

P/B Ratio

Price to book value ratio

-7.27

vs 25 benchmark

P/S Ratio

Price to sales ratio

6.80

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.81

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.24

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.26

vs 25 benchmark

ROA

Return on assets percentage

-0.17

vs 25 benchmark

ROCE

Return on capital employed

0.18

vs 25 benchmark

How XCRT Stacks Against Its Sector Peers

MetricXCRT ValueSector AveragePerformance
P/E Ratio-29.7929.43 Better (Cheaper)
ROE26.34%684.00% Weak
Net Margin-22.83%-45067.00% (disorted) Weak
Debt/Equity-1.810.43 Strong (Low Leverage)
Current Ratio0.244.07 Weak Liquidity
ROA-17.08%-17158.00% (disorted) Weak

XCRT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Xcelerate Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ